Federal Research Institute Of Pediatric Hematology, Oncology And Immunology

This study tested a combination of two existing drugs, secukinumab and dupilumab, to treat severe Netherton syndrome in children. Fifteen pediatric patients received the treatment for at least three months. The goal was to see if this drug combination could safely control the sev…